The mechanism of action of particulate vaccine adjuvants
Citation:Fiona A. Sharp, 'The mechanism of action of particulate vaccine adjuvants', [thesis], Trinity College (Dublin, Ireland). School of Biochemistry and Immunology, 2010, pp 329
Sharp TCD THESIS 8996 The mechanism.pdf (PDF) 142.6Mb
Particulate vaccine adjuvants (PVA) have been used in vaccines both experimentally and clinically for almost a century. However, the mechanisms by which adjuvants, such as alum and poly lactide-co-glycolide (PLG) microparticles promote immune responses are not well understood. This project set out to investigate the mechanisms by which PVA promote immune responses and the relationship between specific PVA characteristics and the induction of innate and adaptive immunity. Firstly, the ability of PVA to activate immune cells in vitro was investigated. These studies revealed that neither alum, PLG nor polystyrene (PS) microparticles promoted the maturation of dendritic cells (DC). Furthermore, the particulates did not directly promote cytokine production by DC. In contrast, PVA synergised with TLR agonists to dramatically enhance the secretion of IL-1β, IL-18 and IL-1α. The enhancement in IL-1β secretion was dependent on particle uptake and potassium efflux. Furthermore, the increase in IL-1β secretion was dependent on caspase-1 activation via the NLRP3 inflammasome.
Author: Sharp, Fiona A.
Qualification name:Doctor of Philosophy (Ph.D.)
Publisher:Trinity College (Dublin, Ireland). School of Biochemistry and Immunology
Note:TARA (Trinity’s Access to Research Archive) has a robust takedown policy. Please contact us if you have any concerns: firstname.lastname@example.org
Type of material:thesis
Availability:Full text available